Dxcover
Created in 2016
Up & running (A)
Existing signals show a regular activitySocial networks
665 2,013Activities
Technologies
Entity types
Location
99 George St, Glasgow G1 1RD, UK
GLASGOW
United Kingdom
Employees
Scale: 11-50
Estimated: 24
Engaged catalyst
3
0 0Added in Motherbase
5 years, 10 months ago
Value proposition
The Future of Cancer Diagnostics
Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has pioneered the early detection and identification of cancer employing infrared spectroscopy of circulating pan-omic biomarkers. The company has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers. Dxcover is based in Scotland, United Kingdom and is establishing operations in the USA.
Clinical diagnostics and Serum testing
Dxcover | The Future of Cancer Diagnostics
Dxcover is a multi-omic platform revolutionizing early cancer detection for multiple cancers powered by light and machine learning.
https://www.dxcover.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Sifted Newspaper Publishing | Sifted Newspaper Publishing | Other 2 Oct 2024 | | |
 UK Research and Innovation Public business cluster, Government Administration | UK Research and Innovation Public business cluster, Government Administration | Other 14 Jan 2021 | | |
 KPMG Consulting, audit, Accounting | KPMG Consulting, audit, Accounting | Not capitalistic Not partnership Event 12 Feb 2020 | | |